Arch Venture Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	$1.77M	Sell	20,000 -20,000	-50%	-$1.77M	8.83%	3
2020 Q2	$4.26M	Sell	40,000 -266,382	-87%	-$28.4M	14.35%	3
2020 Q1	$18.2M	Sell	306,382 -25,000	-8%	-$1.48M	30.67%	2
2019 Q4	$22.9M	Sell	331,382 -54,123	-14%	-$3.74M	29.84%	2
2019 Q3	$40M	Buy	+385,505	New	+$40M	43.8%	1